Genes co-amplified with ERBB2 (GRB7, MIEN1, PGAP3, and STARD3) exhibited the highest amplification frequency in esophageal cancer, followed by stomach, breast, uterine, and bladder cancer (Figure 8B). The gene discussed is PGAP3; the disease is urinary bladder cancer.